Haemonetics (HAE) Environmental, Social & Governance (ESG) Data

Company Profile

Search within these filings

View filings

Exhibits within filings

Filing insights

Export filings list

Export a CSV file of filings or unique filing companies (up to first 5,000 results).

Download list of filings Download list of companies

External links

Employees

Data from SEC filings

Employee count

CEO pay ratio

CEO Salary

Median Employee Salary

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Clean Climate Climate Change Conflict Minerals Emission Environment Environmental Environmental Protection Extreme Weather Life Cycle Lifecycle Materials Mineral Nature Offset Package Packaging Pandemic Petroleum Plastic Raw Materials Regenerative Waste Access Asian Attrition Benefits Black California Consumer Privacy Act Community Culture Customer Cyber Cybersecurity Data Privacy Death Disability Diversity Employee Employee Engagement Engagement Ethnicity Gender General Data Protection Regulation Health and Safety Health Care Healthcare Hire Hiring Human Capital Human Resources Incident Injuries Injury Pay for Performance Perquisites Philanthropy Privacy Product Quality Recall Recruit Reimbursement Resource Group Retention Retirement Safety Satisfaction Skilled Skills Social Societal Society Stakeholder Supplier Supply Chain Supply Chain Management Talent Training Union Women Workforce Action Plan Anti-corruption Assessment Assurance Audit Board Evaluation Board Oversight Board Refreshment Bonus Bribery Classified Classified Board Clawback Commitment Committee Evaluation Corporate Governance Corruption Department of Director Resignation Enterprise Risk Management ESG Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Incentivize Independence Independent Independent Chair Innovate Innovation Innovative Investigation Key Performance Indicator Lawsuit Leadership Litigation Long-term Majority Mission Other Public Company Boards Oversee Oversight Perquisite Plaintiff Pledging Poison Pill Procurement Proxy Contest Purpose Quality Standard R&D Reputation Reputational Research and Development Resilient Responsibility Responsible Right to Call Special Meetings Self-evaluation Shareholder Engagement Shareholder Proposals Special Meeting Stewardship Strategy Sustainability Sustainable Targets Tax Tenure Term Limit Transparency Transparent

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

The Company’s 2022 Annual Meeting of Shareholders was held on Friday, August 5, 2022. Of the 51,299,384 shares outstanding and entitled to vote at the meeting, 48,277,405 shares were represented at the meeting, constituting a quorum of 94.1%.

The results of the votes for each proposal considered at the meeting are set forth below:

1. The shareholders elected each of Christopher A. Simon, Robert E. Abernathy, Catherine M. Burzik, Michael J. Coyle, Charles J. Dockendorff, Lloyd E. Johnson, Mark W. Kroll, Claire Pomeroy and Ellen M. Zane as directors for one-year terms expiring in 2023 based upon the following votes:

Nominees	For	Withhold	Broker Non-Votes

Christopher A. Simon	46,542,318	212,374	1,522,713
Robert E. Abernathy	46,259,954	494,738	1,522,713
Catherine M. Burzik	46,056,687	698,005	1,522,713
Michael J. Coyle	45,582,811	1,171,881	1,522,713
Charles J. Dockendorff	40,796,341	5,958,351	1,522,713
Lloyd E. Johnson	46,073,391	681,301	1,522,713
Mark W. Kroll	45,970,938	783,754	1,522,713
Claire Pomeroy	46,413,784	340,908	1,522,713
Ellen M. Zane	43,483,459	3,271,233	1,522,713

2. The shareholders approved, on an advisory basis, the compensation of the Company’s named executive officers based upon the following votes:

For						Against						Abstain						Broker Non-Votes

43,981,976						2,707,158						65,558						1,522,713

3. The shareholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending April 1, 2023 based upon the following votes:


For	Against	Abstain
47,093,554	1,157,216	26,635